KR930702506A - C형 간염 바이러스 항체 - Google Patents
C형 간염 바이러스 항체Info
- Publication number
- KR930702506A KR930702506A KR1019930701073A KR930701073A KR930702506A KR 930702506 A KR930702506 A KR 930702506A KR 1019930701073 A KR1019930701073 A KR 1019930701073A KR 930701073 A KR930701073 A KR 930701073A KR 930702506 A KR930702506 A KR 930702506A
- Authority
- KR
- South Korea
- Prior art keywords
- antibody
- plasma
- hepatitis
- virus
- produced
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title claims abstract 7
- 239000000427 antigen Substances 0.000 claims abstract 6
- 102000036639 antigens Human genes 0.000 claims abstract 6
- 108091007433 antigens Proteins 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims abstract 4
- 241000700605 Viruses Species 0.000 claims abstract 3
- 238000003018 immunoassay Methods 0.000 claims abstract 2
- 239000002245 particle Substances 0.000 claims abstract 2
- 210000004027 cell Anatomy 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 208000037319 Hepatitis infectious Diseases 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 2
- 208000005252 hepatitis A Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 238000005453 pelletization Methods 0.000 claims 2
- 239000011148 porous material Substances 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 241000282579 Pan Species 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59681190A | 1990-10-12 | 1990-10-12 | |
| US07/596,811 | 1990-10-12 | ||
| PCT/US1991/007571 WO1992007001A1 (en) | 1990-10-12 | 1991-10-09 | Hepatitis c virus antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR930702506A true KR930702506A (ko) | 1993-09-09 |
Family
ID=24388816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019930701073A KR930702506A (ko) | 1990-10-12 | 1991-10-09 | C형 간염 바이러스 항체 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0552297A1 (ja) |
| JP (1) | JPH06502075A (ja) |
| KR (1) | KR930702506A (ja) |
| AU (1) | AU663064B2 (ja) |
| CA (1) | CA2093919A1 (ja) |
| TW (1) | TW216797B (ja) |
| WO (1) | WO1992007001A1 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0556320T3 (da) * | 1990-11-07 | 1999-10-18 | Abbott Lab | Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf |
| JP3217600B2 (ja) * | 1994-07-12 | 2001-10-09 | 株式会社先端生命科学研究所 | 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ |
| ES2377968T3 (es) | 2003-04-01 | 2012-04-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anticuerpos dirigidos contra el complejo E1E2 del virus de la hepatitis C y composiciones farmacéuticas |
| NZ579706A (en) | 2007-02-21 | 2012-03-30 | Univ Massachusetts | Human antibodues against hepatitis C virus (HCV) E2 protein and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU216017B (hu) * | 1987-11-18 | 1999-04-28 | Chiron Corp. | Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt |
| AU632271B2 (en) * | 1988-03-30 | 1992-12-24 | Abbott Laboratories | Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver |
-
1991
- 1991-10-09 KR KR1019930701073A patent/KR930702506A/ko not_active Application Discontinuation
- 1991-10-09 AU AU89457/91A patent/AU663064B2/en not_active Expired - Fee Related
- 1991-10-09 CA CA002093919A patent/CA2093919A1/en not_active Abandoned
- 1991-10-09 WO PCT/US1991/007571 patent/WO1992007001A1/en not_active Application Discontinuation
- 1991-10-09 JP JP3518583A patent/JPH06502075A/ja active Pending
- 1991-10-09 EP EP91920333A patent/EP0552297A1/en not_active Withdrawn
- 1991-11-02 TW TW080108674A patent/TW216797B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992007001A1 (en) | 1992-04-30 |
| AU663064B2 (en) | 1995-09-28 |
| CA2093919A1 (en) | 1992-04-13 |
| JPH06502075A (ja) | 1994-03-10 |
| AU8945791A (en) | 1992-05-20 |
| TW216797B (ja) | 1993-12-01 |
| EP0552297A1 (en) | 1993-07-28 |
| EP0552297A4 (ja) | 1994-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4270751B2 (ja) | 全血用クロマトグラフィーデバイス内のポリカチオンの中和 | |
| Locarnini et al. | Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A-specific immunoglobulin M | |
| FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
| Ruangjirachuporn et al. | Circulating immune complexes in serum from patients with dengue haemorrhagic fever. | |
| Pinon et al. | An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis | |
| Cox et al. | Cytomegaloviremia in children with acute lymphocytic leukemia | |
| NL1008738C2 (nl) | Vaste-fase methode voor antigeen- en antistof bepalingen in de bloedgroepserologie, en testkit. | |
| Pyndiah et al. | Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence | |
| Dreesman et al. | Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats | |
| CA2049679A1 (en) | Hepatitis c assay utilizing recombinant antigens | |
| Thomas | Antibodies specific for human T lymphocytes in cold agglutinin and lymphocytotoxic sera | |
| Boonpucknavig et al. | Immunofluorescent staining of the surfaces of lymphocytes in suspension from patients with dengue hemorrhagic fever. | |
| Westaway | Antibody responses in rabbits to the group B arbovirus Kunjin: Serologic activity of the fractionated immunoglobulins in homologous and heterologous reactions | |
| Vejtorp | Enzyme‐linked immunosorbent assay for determination of rubella IgG antibodies | |
| JPH08242849A (ja) | 限外濾過によるタンパク質溶液からのウイルスの除去 | |
| KR930702506A (ko) | C형 간염 바이러스 항체 | |
| Ades et al. | Analysis of mononuclear cell surfaces with fluoresceinated Staphylococcal protein A complexed with IgG antibody or heat-aggregated γ-globulin | |
| Gray et al. | The rapid serological diagnosis of infectious mononucleosis | |
| Fiorini et al. | Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia. | |
| Penttinen et al. | Platelet aggregation and cryo-IgM in the study of hepatitis and immune complex states | |
| Bux et al. | Alloimmune neonatal neutropenia resulting from immunization to a high‐frequency antigen on the granulocyte Fc gamma receptor III | |
| Cremer et al. | Role of rheumatoid factor in complement fixation and indirect hemagglutination tests for immunoglobulin M antibody to cytomegalovirus | |
| Crawford et al. | Epstein-Barr (EB) virus infection in homosexual men in London. | |
| Winiarski | Mechanisms in childhood idiopathic thrombocytopenic purpura (ITP) | |
| Booth et al. | Cytomegalovlrus complement‐fixing igm antibody |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |